Daily Coverage
Photo Gallery
Meeting Program
Registration
Daily Coverage
Advancing Science in San Juan
SGO President Karen Lu, MD, gives a preview of the amazing science you won't want to miss at this year's SGO Annual Meeting.
Home
Tricky But Treatable
Home
Q&A With SGO President Amanda Nickles Fader, MD
Daily Coverage
Empowering Teams in San Juan
Daily Coverage
Embracing Change in San Juan
Daily Coverage
Explore the SGO 2026 Annual Meeting Schedule
Four days packed with masterclasses, focused forums, oral abstracts, and more science.
Home
Save the date for SGO 2026 Annual Meeting on Women’s Cancer
See you in Puerto Rico!
Sponsored
View the current issue of Gynecologic Oncology
Home
Get to Know SGO’s Incoming President
Karen Lu, MD, brings a strong background and passion for building the gynecologic oncology community.
Home
SGO and FWC Leadership Award Winners
Twelve individuals are recognized for their work in research and service.
Home
A Potential New Detection Tool for Invasive Cervical Cancer
Circulating human papilloma virus DNA shows promise as a universal biomarker.
Interesting Stories
Sponsored by Daiichi Sankyo
Explore our DXd ADC Technology
Sponsored by SGO
View the current issue of Gynecologic Oncology
Sponsored by SGO
Coding Corner: Intra-abdominal Tumor Excision or Destruction Code Changes
Sponsored by AbbVie
Step into new possibilities
Sponsored by Verastem
Click here to learn more about Avmapki Fakzynja Co-Pack
Sponsored by SGO
Learn More About Wellness Programs
Home
Empowering Progress: The Foundation for Women's Cancer
The 2025 FWC strategic plan sets the course to improve outcomes for all patients.
Home
Shaping the Next Generation of Leaders
The SGO LEAD 2.0 Summit, prior to the SGO 2025 Annual Meeting on Women’s Cancer, provided an opportunity for mentees to meet in person and expand their learning experience.
Home
Streamlining Surgery to Enhance Outcomes
Rise of de-escalation trends requires educational shift to transform disease management.
Daily Coverage
A Potential Second-Line Treatment for Cervical Cancer
Combining BVAC-C and durvalumab in recurrent or metastatic cervical cancer.
Home
An Alternative Approach to Preventing Ovarian Cancer?
The ongoing TUBA-WISP II study could point the way to a new preventive approach for those at high risk for tubo-ovarian cancer.
Home
Changing the Course for First-Line, Low-Risk Gestational Trophoblastic Neoplasia
Study marks first substantial cohort enrollment and analysis of this nature.
Home
It’s Time to Change the Diagnosis Protocol for Endometrial Cancer
Home
Durvalumab Plus Carboplatin and Paclitaxel Delivers One-Two Punch for Endometrial Cancer Treatment
Home
Pembrolizumab Plus Chemotherapy Regimen Yields Clinically Positive Outcomes for Treatment of Locally Advanced Cervical Cancer
Daily Coverage
Watch: Welcome to Seattle
Home
Masterclasses and Hands-On Learning Set the Pace for SGO 2025
Home
Get the SGO 2025 Mobile App
Home
Fund the Future. Honor a Legacy
Home
Invited Speaker: Gretchen Schwarze
Home
Invited Speaker: Monica Bertagnolli
Home
Invited Speaker: Jonathan Perlin
Home
Author Liz Wiseman to Speak at Presidential Session
Home
Housing and Travel for SGO 2025 Annual Meeting on Women’s Cancer